Search Results - "Smolej, L."

Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force by Stauder, R., Eichhorst, B., Hamaker, M.E., Kaplanov, K., Morrison, V.A., Österborg, A., Poddubnaya, I., Woyach, J.A., Shanafelt, T., Smolej, L., Ysebaert, L., Goede, V.

“…Chronic lymphocytic leukemia (CLL) mainly affects older people: the median age at diagnosis is > 70 years. Elderly patients with CLL are heterogeneous with…”
Get full text

OUTCOMES OF THE TREATMENT AFTER ANTI‐CD19 CAR‐T THERAPY FAILURE IN PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA—ANALYSIS OF DATA FROM THE CZECH REPUBLIC by Sýkorová, A., Polgárová, K., Folber, F., Ďuraš, J., Móciková, H., Steinerová, K., Obr, A., Belada, D., Smolej, L., Trněný, M., Pytlík, R.

Get full text

Venous thromboembolism in patients with chronic lymphocytic leukemia by Šimkovič, M, Vodárek, P, Motyčková, M, Belada, D, Vrbacký, F, Žák, P, Smolej, L

“…Abstract Introduction Venous thromboembolism (VTE) is a major cause of morbidity and mortality in patients (pts) with malignant tumors. Increased risk of VTE…”
Get full text

Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome by Belohlavkova, P, Vrbacky, F, Smolej, L, Radocha, J, Lanska, M, Visek, B, Kupsa, T, Zavrelova, A, Zak, P

“…In the present study, we retrospectively analysed the results of HSCT in 47 consecutive patients with MDS diagnosed at our department between 2002 and 2019,…”
Get full text

Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies by Kralickova, P., Kuhnova, J., Soucek, O., Vodarek, P., Zak, P., Simkovic, M., Motyckova, M., Smolej, L., Mala, E., Andrys, C., Krejsek, J., Thon, V.

“…Humoral deficiencies represent a broad group of disorders. The aim of the study was to compare the levels of antibodies against pneumococcal capsular…”
Get full text

P676: LOW‐DOSE FCR COMPARED TO BR IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT TP53 ABERRATIONS: A REAL – WORLD RETROSPECTIVE ANALYSIS BY THE CZECH CLL STUDY GROUP by Smolej, L., Brychtová, Y., Cmunt, E., Oršulová, M., Vodárek, P., Dostál, M., Turcsányi, P., Urbanová, R., Panovská, A., Zuchnická, J., Mihályová, J., Lysák, D., Brejcha, M., Móciková, H., Klásková, K., Šimkovič, M., Špaček, M., Doubek, M.

Get full text

Why R-CHOP for first line treatment of chronic lymphocytic leukemia? by Smolej, L.

Get full text

Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network by Cheah, C.Y., George, A., Giné, E., Chiappella, A., Kluin-Nelemans, H.C., Jurczak, W., Krawczyk, K., Mocikova, H., Klener, P., Salek, D., Walewski, J., Szymczyk, M., Smolej, L., Auer, R.L., Ritchie, D.S., Arcaini, L., Williams, M.E., Dreyling, M., Seymour, J.F.

“…Central nervous system (CNS) involvement in mantle cell lymphoma (MCL) is uncommon, and the manifestations and natural history are not well described. We…”
Get full text

Pitfalls and limitations of ZAP-70 detection in chronic lymphocytic leukemia by Vroblova, V, Smolej, L, Krejsek, J

“…Zeta-associated protein of 70 kDa (ZAP-70) is a tyrosine kinase that plays a role in signal transduction from the T-cell receptor. ZAP-70 is expressed in…”
Get more information

Burkitt lymphoma–multicenter retrospective data analysis from the Czech Lymphoma Study Group–NiHiL project by Sýkorová, A., Pytlík, R., Móciková, H., Janíková, A., Procházka, V., Belada, D., Šálek, D., Benešová, K., Klener, P., Ďuraš, J., Smolej, L., Šimkovič, M., Campr, V., Vosáhlová, V., Blahovcová, P., Trněný, M.

Get full text

Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia by SMOLEJ, L, KAŠPAROVÁ, P

“…Angiogenesis is a potential prognostic factor in chronic lymphocytic leukemia (CLL). Elevated circulating levels of angiogenic factors in CLL have been…”
Get full text

Prognostic relevance of angiopoietin-2, fibroblast growth factor-2 and endoglin mRNA expressions in chronic lymphocytic leukemia by Vrbacky, F, Nekvindova, J, Rezacova, V, Simkovic, M, Motyckova, M, Belada, D, Painuly, U, Jiruchova, Z, Maly, J, Krejsek, J, Zak, P, Cervinka, M, Smolej, L

“…Elevated levels of circulating angiogenic cytokines and increased expression of genes encoding angiogenic factors have been reported in recent years in…”
Get more information

5.45 Rituximab Infusion-Related Toxicity In Patients With CLL by Simkovic, M, Motyckova, M, Belada, D, Maly, J, Smolej, L

Get full text

Quantification of ZAP-70 expression in chronic lymphocytic leukemia: T/B-cell ratio of mean fluorescence intensity provides stronger prognostic value than percentage of positive cells by Smolej, L, Vroblova, V, Motyckova, M, Jankovicova, K, Schmitzova, D, Krejsek, J, Maly, J

“…Expression of ZAP-70 measured by flow cytometry belongs to the most powerful prognostic parameters in chronic lymphocytic leukemia (CLL). However, many…”
Get more information

Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features by Vrbacky, F, Smolej, L, Vroblova, V, Pekova, S, Hrudkova, M, Cervinka, M, Pecka, M, Krejsek, J, Maly, J

“…Several studies have demonstrated the potential prognostic importance of angiogenesis in chronic lymphocytic leukemia (CLL). Elevated expression of…”
Get more information

Expression of ZAP-70 in patients with chronic lymphocytic leukemia may change significantly during the course of the disease by Smolej, L., Vroblova, V., Novosad, J.

Get full text

Isotype class switching after transplantation in multiple myeloma by Maisnar, V, Tichý, M, Smolej, L, Zák, P, Radocha, J, Palicka, V, Malý, J, Bláha, V

“…Switching of the paraprotein isotype or transient presence of oligoclonal bands detectable by serum immunofixation electrophoresis has been reported following…”
Get more information

Therapeutic Options for "Slow go" Patients with Chronic Lymphocytic Leukemia by Smolej, L

“…Chronic lymphocytic leukemia is a disease of older patients, most of them suffering from significant comorbidities or functional limitations (so -called 'slow-…”
Get more information

Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab by Smolej, Lukáš

“…Introduction of targeted agents revolutionized the treatment of chronic lymphocytic leukemia (CLL) in the past decade. Addition of chimeric monoclonal…”
Get full text

Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemiaa by SMOLEJ, L, Kasparova, P

“…Smolej L. Kasparova P. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia. APMIS 2008;…”
Get full text